Skip to content

Uterine Contractions Under Blue Light

Nightly Suppression of Contractions in At-Risk Pregnancies by the Infusion of Defused Blue Light

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03691740
Enrollment
30
Registered
2018-10-02
Start date
2018-09-06
Completion date
2019-06-30
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Contractions

Keywords

circadian, melatonin, preterm labor

Brief summary

The objective in the current study is to test the hypothesis that nocturnal uterine contractions in preterm women can be suppressed by brief ocular exposure to blue light.The Olcese lab at Florida State University identified a novel interaction between the myometrial melatonin receptors and OT receptors in human myometrial cells (Sharkey et al. 2009), which may ultimately help to resolve certain issues surrounding idiopathic preterm labor. Their results consistently indicate that melatonin at physiological concentration sensitizes human myometrial smooth muscle cells to the contractile effects of OT (Sharkey et al. 2010).

Detailed description

Study participants will be pregnant women (gestational weeks 24 to 31+6 days) who present with preterm contractions. In the triage room, the study participant will be connected to the external tocometer from at least 19:00h (7 PM) to the following morning at 07:00h. Room lighting will be kept dim. Participants meeting inclusion criteria will be randomly allocated to blue light or red light. Baseline contractions will be measured. The allocated light mask will be applied for 2 intervals of 60 minutes each.There will be a 60 minute rest period after every 60 minute intervention period for comparison. Other than the application of the light mask, all routine standards of care deemed warranted by the obstetric provider for proper treatment of preterm labor will be followed. (ie antenatal steroids, tocolytics).

Interventions

DEVICEOcular light

A light mask to which small light emitting diode(LED) lights emitting a blue or red color light will be used to deliver ocular light

Sponsors

Kyndermed
CollaboratorUNKNOWN
University of South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

Study group assignments will be placed in an opaque envelope which will be kept in the designated research area on Labor and Delivery. After informed consent is obtained, the coordinator will take one of the envelopes to determine the study group. The coordinator will not communicate with the care provide or the investigator regarding study group assignment.

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant * Gestational age: 24 to 31 (+6 days) week of pregnancy * Uterine contractions * First episode of preterm labor

Exclusion criteria

* Visual impairment (legally blind) * Multiple pregnancy * Current progesterone treatment * Preeclampsia * Renal disease * Current chlamydia or gonorrhea infections * Cocaine or opiate use * Nightshift work in the past week

Design outcomes

Primary

MeasureTime frameDescription
Number of contractions per hourImmediately upon completion of interventionNumber of contractions per hour

Secondary

MeasureTime frameDescription
Binary proportion of 4 or less compared to 5+ contractions per hourImmediately upon completion of interventionCompare proportion proportions among each treatment group

Countries

United States

Contacts

Primary ContactJudette M Louis, MD
jlouis1@health.usf.edu8132598500
Backup ContactLinda Odibo, RN, BSc, MN
lodibo@health.usf.edu(813) 259-0655

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026